GRI Bio Inc. (GRI)
NASDAQ: GRI
· Real-Time Price · USD
1.40
-0.04 (-2.78%)
At close: Aug 15, 2025, 3:59 PM
1.44
2.86%
After-hours: Aug 15, 2025, 07:46 PM EDT
GRI Bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1K | n/a | n/a | 1K | 3K | 3K | 3K | 171K | 187K | 206K | 224K | 74K | 66K | 75K | 76K | 57K | 47K |
Gross Profit | -1K | n/a | n/a | -1K | -3K | -3K | -3K | -171K | -187K | -206K | -224K | -74K | -66K | -75K | -76K | -57K | -47K |
Operating Income | -9.39M | -8.23M | -8.31M | -8.62M | -12.29M | -12.75M | -12.11M | -11.07M | -6.64M | -6.93M | -8.64M | -8.49M | -9.29M | -9.26M | -7.63M | -7.41M | -6.23M |
Interest Income | 24K | 25K | 26K | 25K | 19K | 29K | 48K | 44K | 44K | 28K | 2K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -9.37M | -8.21M | -8.26M | -8.28M | -12.77M | -13.28M | -12.86M | -11.76M | -6.79M | -7.02M | -8.54M | -8.76M | -9.3M | -9.3M | -7.68M | -7.46M | -6.3M |
Net Income | -9.37M | -8.21M | -8.26M | -8.28M | -12.77M | -13.28M | -12.86M | -11.76M | -6.79M | -7.02M | -8.54M | -8.76M | -9.3M | -9.3M | -7.68M | -7.46M | -6.3M |
Selling & General & Admin | 4.92M | 4.47M | 4.32M | 4.57M | 8.24M | 9.75M | 10.52M | 10.52M | 6.68M | 5.55M | 4.88M | 4.65M | 4.54M | 4M | 3.08M | 2.36M | 1.59M |
Research & Development | 4.47M | 3.77M | 3.99M | 4.04M | 4.05M | 2.99M | 1.59M | 379K | -223K | 1.17M | 3.53M | 3.76M | 4.69M | 5.19M | 4.47M | 4.99M | 4.59M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 9.39M | 8.23M | 8.31M | 8.62M | 12.29M | 12.74M | 12.1M | 10.9M | 6.46M | 6.72M | 8.41M | 8.41M | 9.22M | 9.18M | 7.55M | 7.35M | 6.18M |
Interest Expense | n/a | n/a | n/a | n/a | 934K | 934K | 934K | 934K | 1K | 2K | 4K | 8K | 9K | 16K | 23K | 31K | 41K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.39M | 8.23M | 8.31M | 3.74M | -4.45M | -8.7M | -12.11M | -11.07M | -6.64M | -6.93M | -8.64M | -8.49M | -9.29M | -9.26M | -7.63M | -7.41M | -6.23M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 525.45K | 183.28K | 185.93K | 457.73K | 317.49K | 49.67K | 45.32K | 26.57K | 49.39K | 49.39K | 44.34K | 31.81K | 24.96K | 24.96K | 24.96K | 24.96K | 24.96K |
Shares Outstanding (Diluted) | 525.45K | 183.28K | 185.93K | 457.73K | 317.49K | 49.67K | 45.32K | 26.57K | 49.39K | 49.39K | 44.34K | 31.81K | 24.96K | 24.96K | 24.96K | 24.96K | 24.96K |
EPS (Basic) | 40.03 | -55.21 | -881.88 | -1.67K | -5.9K | -14.05K | -18.81K | -21.97K | -27.13K | -36.83K | -52.48K | -57.08K | -63.35K | -63.37K | -52.29K | -50.85K | -42.92K |
EPS (Diluted) | 40.03 | -55.21 | -881.88 | -1.67K | -5.9K | -14.05K | -18.81K | -21.97K | -27.13K | -36.83K | -52.48K | -57.08K | -63.35K | -63.37K | -52.29K | -50.85K | -42.92K |
EBITDA | -9.39M | -8.23M | -7.87M | -7.88M | -11.43M | -11.94M | -11.93M | -10.65M | -6.6M | -6.82M | -8.37M | -8.74M | -9.29M | -9.27M | -7.58M | -7.38M | -6.21M |
EBIT | -9.39M | -8.23M | -7.88M | -7.88M | -11.44M | -11.94M | -11.93M | -10.82M | -6.78M | -7.02M | -8.59M | -8.81M | -9.35M | -9.35M | -7.65M | -7.43M | -6.26M |
Depreciation & Amortization | 4K | 4K | 18K | 18K | 19K | 18K | 3K | 171K | 187K | 206K | 224K | 74K | 66K | 75K | 76K | 57K | 47K |